BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Investors
/
Monograph Capital
Monograph Capital
Biotech Investor · 5 portfolio companies
Portfolio
5
Focus Areas
11
Top Stage
Pre-clinical
Investment Focus
Immunology
Rare Disease
Rheumatoid Arthritis
Chronic Inflammatory Diseases
Neurodegenerative Diseases
Ophthalmology
Obesity
Metabolic Diseases
Chronic Pain
Autoimmunity
Cardiovascular Disease
Portfolio Companies
Company
Stage
Valuation
Focus
Human Immunology Biosciences (HI-Bio)
phase-2
—
Immunology, Rare Disease
Elevara Medicines
Phase 2
—
Rheumatoid Arthritis, Chronic Inflammatory Diseases
AviadoBio
Phase 1
—
Neurodegenerative Diseases, Ophthalmology
ProLynx
Pre-clinical
—
Obesity, Metabolic Diseases
Maxion Therapeutics
Pre-clinical
—
Chronic Pain, Autoimmunity
Frequent Co-Investors
LifeArc Ventures
2 shared
OrbiMed
1 shared
5AM Ventures
1 shared
ARCH Venture Partners
1 shared
General Catalyst
1 shared
Johnson & Johnson Innovation – JJDC
1 shared
Sofinnova Partners
1 shared
F-Prime Capital
1 shared